Dr. Sang is a scientist and entrepreneur with extensive experience in technology development, partnering and commercialization. Prior to founding Accure Health, Dr. Sang was a research investigator at Harvard University where she focused on developing cutting-edge technology platforms for liquid biopsy. Earlier in her career, Dr. Sang worked at Genentech and successfully led international projects across six countries to identify novel targets for therapeutic development. She serves on Grant review committees and also as Principal Investigator (PI) of programs funded by the National Institute of Health. Her work in cancer, genomics and proteomics has been published in leading scientific journals, including first-author publications in Science and Cell.

Dr. Sang is a member of the American Association for the Advancement of Science (AAAS), the American Society of Clinical Oncology (ASCO), and the Forbes Business Council. She received her Ph.D. in Molecular and Cellular Biology from University of Washington / Fred Hutchinson Cancer Research Center, where she was an HHMI Graduate Fellow.